Investigational Site Number 8400060 — South Burlington, Vermont

Investigational Site Number 8400060 is a clinical research site located in South Burlington, Vermont, United States 05403.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 8400060 has participated in 1 clinical trials.

Therapeutic areas: Heart Failure, Type 2 Diabetes Mellitus, Chronic Kidney Diseases.

Sponsors: Lexicon Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 8400060?

Investigational Site Number 8400060 has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 8400060 conducted?

Investigational Site Number 8400060 has 1 clinical trials on record. Their work covers Heart Failure, Type 2 Diabetes Mellitus, Chronic Kidney Diseases.

Is Investigational Site Number 8400060 accredited by Crixeo Health?

Investigational Site Number 8400060 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 8400060?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.